We are live on ! Find out more
BCRX icon

BioCryst Pharmaceuticals
BCRX

103 hedge funds and large institutions have $248M invested in BioCryst Pharmaceuticals in 2016 Q3 according to their latest regulatory filings, with 13 funds opening new positions, 29 increasing their positions, 29 reducing their positions, and 10 closing their positions.

New
Increased
Maintained
Reduced
Closed

68% more capital invested

Capital invested by funds: $147M → $248M (+$100M)

30% more first-time investments, than exits

New positions opened: 13 | Existing positions closed: 10

3% more funds holding

Funds holding: 100 → 103 (+3)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

0% more repeat investments, than reductions

Existing positions increased: 29 | Existing positions reduced: 29

6% less call options, than puts

Call options by funds: $5.36M | Put options by funds: $5.71M

Holders
103
Holders Change
+3
Holders Change %
+3%
% of All Funds
2.75%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.08%
New
13
Increased
29
Reduced
29
Closed
10
Calls
$5.36M
Puts
$5.71M
Net Calls
-$348K
Net Calls Change
-$548K

Top Buyers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
+$17.6M
2
RI
RTW Investments
New York
+$7.86M
3
ACA
Avoro Capital Advisors
New York
+$5.51M
4
Invesco
Invesco
Georgia
+$3.86M
5
ACP
Acuta Capital Partners
California
+$2.21M

Top Sellers

Rank Fund Capital Flow
1
BBA
Baker Bros. Advisors
New York
-$16.2M
2
TCM
Tang Capital Management
California
-$1.22M
3
GC
Globeflex Capital
California
-$1.17M
4
Goldman Sachs
Goldman Sachs
New York
-$996K
5
Wellington Management Group
Wellington Management Group
Massachusetts
-$727K
Name Holding Trade Value Shares
Change 		Change in
Stake
HCM
26
Highbridge Capital Management
New York
$780K +$178K +44,674 +34%
PP
27
PDT Partners
New York
$714K +$647K +161,900 New
RA
28
Royce & Associates
New York
$706K – – –
California State Teachers Retirement System (CalSTRS)
29
California State Teachers Retirement System (CalSTRS)
California
$686K +$5.59K +1,400 +0.9%
AllianceBernstein
30
AllianceBernstein
Tennessee
$557K -$39.1K -9,800 -7%
California Public Employees Retirement System
31
California Public Employees Retirement System
California
$544K -$34.4K -8,600 -7%
Susquehanna International Group
32
Susquehanna International Group
Pennsylvania
$497K +$102K +25,561 +29%
CS
33
Credit Suisse
Switzerland
$492K -$72.6K -18,166 -14%
TA
34
Teachers Advisors
New York
$468K -$44.9K -11,236 -10%
AC
35
Amici Capital
New York
$441K – – –
Swiss National Bank
36
Swiss National Bank
Switzerland
$425K – – –
CA
37
Corrado Advisors
New Jersey
$420K -$82K -20,530 -18%
UBS Group
38
UBS Group
Switzerland
$389K +$16.3K +4,086 +5%
VEA
39
Virtus ETF Advisers
New York
$374K – – –
RhumbLine Advisers
40
RhumbLine Advisers
Massachusetts
$359K -$76.5K -19,144 -19%
Federated Hermes
41
Federated Hermes
Pennsylvania
$357K -$94.8K -23,722 -23%
New York State Common Retirement Fund
42
New York State Common Retirement Fund
New York
$306K – – –
Wolverine Trading
43
Wolverine Trading
Illinois
$296K +$266K +66,625 New
MLICM
44
Metropolitan Life Insurance Company (MetLife)
New York
$270K -$9.31K -2,330 -4%
Millennium Management
45
Millennium Management
New York
$270K +$124K +31,088 +103%
State Board of Administration of Florida Retirement System
46
State Board of Administration of Florida Retirement System
Florida
$240K – – –
Manulife (Manufacturers Life Insurance)
47
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$238K -$4.98K -1,246 -2%
ProShare Advisors
48
ProShare Advisors
Maryland
$237K -$40.4K -10,106 -16%
FSA
49
Franklin Street Advisors
North Carolina
$216K -$79.9K -20,000 -29%
NFA
50
Nationwide Fund Advisors
Ohio
$214K – – –
1
2
3 4 5

BCRX Hedge Fund Activity: Q3 2016 in Review

103 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in BioCryst Pharmaceuticals (BCRX) for Q3 2016, worth a combined $248M — up 68% from $147M a quarter earlier.

Buyers outnumbered sellers: 13 funds opened new BCRX positions and 10 closed out — a net gain of 3 holders — while 29 added to existing stakes and 29 trimmed.

The largest buyer was Deerfield Management, opening a new position worth an estimated $17.6M. The largest seller was Baker Bros. Advisors, cutting an estimated $16.2M.

  • 103 institutional investors held BioCryst Pharmaceuticals (BCRX) as of Q3 2016, up from 100 in Q2 2016.
  • Funds reported $248M of BioCryst Pharmaceuticals stock for Q3 2016, up 68% quarter-over-quarter.
  • 13 funds opened new BioCryst Pharmaceuticals positions in Q3 2016 and 10 closed out, a net change of +3 holders.
  • The largest BioCryst Pharmaceuticals buyer in Q3 2016 was Deerfield Management, an estimated $17.6M added.
  • The largest BioCryst Pharmaceuticals seller in Q3 2016 was Baker Bros. Advisors, an estimated $16.2M sold.

Based on aggregated 13F filings for Q3 2016.